Ambulatory Infusion Center Market, by Therapy Type (Blood Product Infusion, Iron Therapy, Steroid Infusion, Immunoglobulin Therapy, Therapeutic Phlebotomy, Plasmapheresis, Clotting Factor Replacement Therapy, and Others), by Application (Chronic Inflamma

Ambulatory Infusion Center Market, by Therapy Type (Blood Product Infusion, Iron Therapy, Steroid Infusion, Immunoglobulin Therapy, Therapeutic Phlebotomy, Plasmapheresis, Clotting Factor Replacement Therapy, and Others), by Application (Chronic Inflammatory Disorders, Neurological Disorders, Cancers, Nutrition Support, and Gastro-intestinal Disorders), by Distribution Channel (Hospital, Clinics, and Home Infusion), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

The ambulatory infusion is administration of medications and body fluids for various disorders such as neurological disorders, cancers, chronic inflammation disorders, and nutrition support. The ambulatory infusion centers provide administration of various medication such as antibiotic, chemotherapy, pain management drugs, and others to the patients.
Market Dynamics
Key players are focusing on technological advancement in ambulatory infusion systems to strengthen their position in the global ambulatory infusion center market. For instance, in October 2020, Zyno Solutions, a company focusing on providing Intelligent IV infusion system, launched Nimbus Ambulatory Infusion Pump and the Z-800F Infusion Pump at Immunoglobulin National Society (IgNS) Virtual Conference on October 22-26. Nimbus ambulatory infusion pump is small in size, cost effective, and can meet several ambulatory infusion applications such as bleeding disorders, chronic inflammatory disorders, and cancer.
Key features of the study:
This report studies the current scenario as well as the future potential of the global ambulatory infusion center market. The market for is segmented on basis of therapy type, application, distribution channel, and region.
This report provides in-depth analysis of the global ambulatory infusion center market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
It profiles leading players in the global ambulatory infusion center market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
The global ambulatory infusion center market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global ambulatory infusion center market
Detailed Segmentation:
Global Ambulatory Infusion Center Market, By Therapy Type:
Blood Product Infusion
Iron Therapy
Steroid Infusion
Immunoglobulin Therapy
Therapeutic Phlebotomy
Plasmapheresis
Clotting Factor Replacement Therapy
Others
Global Ambulatory Infusion Center Market, By Application:
Chronic Inflammatory Disorders
Neurological Disorders
Cancers
Nutrition Support
Gastro-intestinal Disorders
Global Ambulatory Infusion Center Market, By Distribution Channel :
Hospital
Clinics
Home Infusion
Global Ambulatory Infusion Center Market, By Region:
North America
By Therapy Type:
Blood Product Infusion
Iron Therapy
Steroid Infusion
Immunoglobulin Therapy
Therapeutic Phlebotomy
Plasmapheresis
Clotting Factor Replacement Therapy
Others
By Application:
Chronic Inflammatory Disorders
Neurological Disorders
Cancers
Nutrition Support
Gastro-intestinal Disorders
By Distribution Channel :
Hospital
Clinics
Home Infusion
By Country:
U.S.
Canada
Latin America
By Therapy Type:
Blood Product Infusion
Iron Therapy
Steroid Infusion
Immunoglobulin Therapy
Therapeutic Phlebotomy
Plasmapheresis
Clotting Factor Replacement Therapy
Others
By Application:
Chronic Inflammatory Disorders
Neurological Disorders
Cancers
Nutrition Support
Gastro-intestinal Disorders
By Distribution Channel :
Hospital
Clinics
Home Infusion
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Therapy Type:
Blood Product Infusion
Iron Therapy
Steroid Infusion
Immunoglobulin Therapy
Therapeutic Phlebotomy
Plasmapheresis
Clotting Factor Replacement Therapy
Others
By Application:
Chronic Inflammatory Disorders
Neurological Disorders
Cancers
Nutrition Support
Gastro-intestinal Disorders
By Distribution Channel :
Hospital
Clinics
Home Infusion
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Therapy Type:
Blood Product Infusion
Iron Therapy
Steroid Infusion
Immunoglobulin Therapy
Therapeutic Phlebotomy
Plasmapheresis
Clotting Factor Replacement Therapy
Others
By Application:
Chronic Inflammatory Disorders
Neurological Disorders
Cancers
Nutrition Support
Gastro-intestinal Disorders
By Distribution Channel :
Hospital
Clinics
Home Infusion
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Therapy Type:
Blood Product Infusion
Iron Therapy
Steroid Infusion
Immunoglobulin Therapy
Therapeutic Phlebotomy
Plasmapheresis
Clotting Factor Replacement Therapy
Others
By Application:
Chronic Inflammatory Disorders
Neurological Disorders
Cancers
Nutrition Support
Gastro-intestinal Disorders
By Distribution Channel :
Hospital
Clinics
Home Infusion
By Country:
GCC
Israel
Rest of Middle East
Africa
By Therapy Type:
Blood Product Infusion
Iron Therapy
Steroid Infusion
Immunoglobulin Therapy
Therapeutic Phlebotomy
Plasmapheresis
Clotting Factor Replacement Therapy
Others
By Application:
Chronic Inflammatory Disorders
Neurological Disorders
Cancers
Nutrition Support
Gastro-intestinal Disorders
By Distribution Channel :
Hospital
Clinics
Home Infusion
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Option Care Health.*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
PharmaScript
Cleveland Clinic
Stoughton Health
Coram CVS
Hattiesburg Clinic
UnitedHealth Group
UK HealthCare
CHI Health
PharMerica
Beacon Health System, Inc.
Arnot Health, Inc.
IVX Health
Precision Healthcare
“*” marked represents similar segmentation in other categories in the respective section.